Trial · NCT00838383
Results by group207
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 207
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change From 0 Hour in Pulmonary Vascular Resistance (PVR) at 0.5 Hour Post-separation From Cardiopulmonary Bypass (CPB) | Sitaxsentan (1 mg/kg) | -7.75 | Standard Deviation 55.277 | percent change | |
| Percent Change From 0 Hour in Pulmonary Vascular Resistance (PVR) at 0.5 Hour Post-separation From Cardiopulmonary Bypass (CPB) | Sitaxsentan (2 mg/kg) | -10.94 | Standard Deviation 37.967 | percent change | |
| Percent Change From 0 Hour in Pulmonary Vascular Resistance (PVR) at 0.5 Hour Post-separation From Cardiopulmonary Bypass (CPB) | Placebo | 62.22 | Standard Deviation 260.172 | percent change | |
| Percent Change From 0 Hour in Pulmonary Vascular Resistance (PVR) at 6 Hour Post-separation From Cardiopulmonary Bypass (CPB) | Sitaxsentan (1 mg/kg) | 39.36 | Standard Deviation 61.615 | percent change | |
| Percent Change From 0 Hour in Pulmonary Vascular Resistance (PVR) at 6 Hour Post-separation From Cardiopulmonary Bypass (CPB) | Sitaxsentan (2 mg/kg) | -12.01 | Standard Deviation 39.561 | percent change | |
| Percent Change From 0 Hour in Pulmonary Vascular Resistance (PVR) at 6 Hour Post-separation From Cardiopulmonary Bypass (CPB) | Placebo | 173.68 | Standard Deviation 511.269 | percent change | |
| Percent Change From 0 Hour in Pulmonary Vascular Resistance (PVR) at 12 Hour Post-separation From Cardiopulmonary Bypass (CPB) | Sitaxsentan (1 mg/kg) | 31.42 | Standard Deviation 67.887 | percent change | |
| Percent Change From 0 Hour in Pulmonary Vascular Resistance (PVR) at 12 Hour Post-separation From Cardiopulmonary Bypass (CPB) | Sitaxsentan (2 mg/kg) | -12.32 | Standard Deviation 37.517 | percent change | |
| Percent Change From 0 Hour in Pulmonary Vascular Resistance (PVR) at 12 Hour Post-separation From Cardiopulmonary Bypass (CPB) | Placebo | 98.03 | Standard Deviation 283.333 | percent change | |
| Percent Change From 0 Hour in Pulmonary Vascular Resistance (PVR) at 24 Hour Post-separation From Cardiopulmonary Bypass (CPB) | Sitaxsentan (1 mg/kg) | 18.06 | Standard Deviation 63.362 | percent change | |
| Percent Change From 0 Hour in Pulmonary Vascular Resistance (PVR) at 24 Hour Post-separation From Cardiopulmonary Bypass (CPB) | Sitaxsentan (2 mg/kg) | -15.99 | Standard Deviation 41.604 | percent change | |
| Percent Change From 0 Hour in Pulmonary Vascular Resistance (PVR) at 24 Hour Post-separation From Cardiopulmonary Bypass (CPB) | Placebo | 195.64 | Standard Deviation 522.379 | percent change | |
| Mortality: Number of Participants Died During Surgery and Initial Hospitalization | Sitaxsentan (1 mg/kg) | During surgery | 0 | participants | |
| Mortality: Number of Participants Died During Surgery and Initial Hospitalization | Sitaxsentan (2 mg/kg) | During surgery | 0 | participants | |
| Mortality: Number of Participants Died During Surgery and Initial Hospitalization | Placebo | During surgery | 0 | participants | |
| Mortality: Number of Participants Died During Surgery and Initial Hospitalization | Sitaxsentan (1 mg/kg) | During initial hospitalization | 2 | participants | |
| Mortality: Number of Participants Died During Surgery and Initial Hospitalization | Sitaxsentan (2 mg/kg) | During initial hospitalization | 1 | participants | |
| Mortality: Number of Participants Died During Surgery and Initial Hospitalization | Placebo | During initial hospitalization | 0 | participants | |
| Number of Participants With Myocardial Infarction, Cerebrovascular Event, Hemodynamic Collapse and Re-operation | Sitaxsentan (1 mg/kg) | Myocardial Infarction | 1 | participants | |
| Number of Participants With Myocardial Infarction, Cerebrovascular Event, Hemodynamic Collapse and Re-operation | Sitaxsentan (2 mg/kg) | Myocardial Infarction | 0 | participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00838383/results